Skip to main content

Alterity Therapeutics Ltd

ATHE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001131343

In the last 90 days, Alterity Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.12M in total; no superinvestor holds it.

Other share classesPRNAF

Members of Congress who traded ATHE

No member of Congress has reported a trade in Alterity Therapeutics Ltd since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.